Correction to: Efficacy and safety of nemolizumab and topical corticosteroids for prurigo nodularis: results from a randomized double-blind placebo-controlled phase II/III clinical study in patients aged ≥ 13 years
- PMID: 39226086
- DOI: 10.1093/bjd/ljae338
Correction to: Efficacy and safety of nemolizumab and topical corticosteroids for prurigo nodularis: results from a randomized double-blind placebo-controlled phase II/III clinical study in patients aged ≥ 13 years
Erratum for
-
Efficacy and safety of nemolizumab and topical corticosteroids for prurigo nodularis: results from a randomized double-blind placebo-controlled phase II/III clinical study in patients aged ≥ 13 years.Br J Dermatol. 2024 Jul 16;191(2):200-208. doi: 10.1093/bjd/ljae131. Br J Dermatol. 2024. PMID: 38629497 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources